Published in Psychopharmacology (Berl) on May 08, 1979
Lithium and cognitive enhancement: leave it or take it? Psychopharmacology (Berl) (2008) 1.45
The effects of lithium on cognition: an updated review. Psychopharmacology (Berl) (2003) 1.14
Lithium-induced constructional dyspraxia. Br Med J (Clin Res Ed) (1983) 0.88
The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 2: Review, grading of the evidence and a precise algorithm. Int J Neuropsychopharmacol (2016) 0.82
The neurocognitive functioning in bipolar disorder: a systematic review of data. Ann Gen Psychiatry (2015) 0.81
Effect of chronic administration of lithium on memory functions of rats. Indian J Psychiatry (1983) 0.77
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res (1997) 4.04
Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci (1995) 3.56
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
Cognitive effects of corticosteroids. Am J Psychiatry (1990) 2.85
Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry (1998) 2.77
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry (1998) 2.69
Anterior paralimbic mediation of procaine-induced emotional and psychosensory experiences. Arch Gen Psychiatry (1996) 2.53
Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry (1995) 2.53
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry (1995) 2.26
DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology (2003) 2.14
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06
Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol (1994) 2.03
Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol (1996) 1.96
Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry (1978) 1.88
Increasing effects of repetitive cocaine administration in the rat. Nature (1976) 1.85
Association of the intrauterine device and pelvic inflammatory disease: a retrospective pilot study. Am J Epidemiol (1974) 1.82
Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet (1996) 1.76
Development of major depression after treatment for smoking cessation. Am J Psychiatry (2000) 1.72
Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry (2000) 1.66
Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population. Am J Med Genet (1996) 1.65
Nicotine, negative affect, and depression. J Consult Clin Psychol (1993) 1.64
Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci (1996) 1.60
Addition of lithium carbonate to carbamazepine: hematological and thyroid effects. Am J Psychiatry (1990) 1.55
Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry (1996) 1.54
Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet (1999) 1.54
Gender differences in regional cerebral blood flow during transient self-induced sadness or happiness. Biol Psychiatry (1996) 1.46
Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry (2001) 1.46
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. J Clin Psychopharmacol (1998) 1.46
A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A (1996) 1.46
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Rash complicating carbamazepine treatment. J Clin Psychopharmacol (1994) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder. Am J Psychiatry (1997) 1.41
Impaired recognition of affect in facial expression in depressed patients. Biol Psychiatry (1992) 1.40
Behavioral genetics. West J Med (1996) 1.39
Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol Psychiatry (2000) 1.38
Fatal infection with Aeromonas hydrophila in a patient with acute myelogenous leukemia. Ann Intern Med (1967) 1.37
Quenching revisited: low level direct current inhibits amygdala-kindled seizures. Exp Neurol (1998) 1.36
Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry (2011) 1.36
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol (2000) 1.33
Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry (1999) 1.33
Regional brain activity when selecting a response despite interference: An H2 (15) O PET study of the stroop and an emotional stroop. Hum Brain Mapp (1994) 1.33
Effects of stress on neurotrophic factor expression in the rat brain. Ann N Y Acad Sci (1995) 1.31
The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl (1985) 1.31
Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biol Psychiatry (1999) 1.28
Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res (1990) 1.25
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry (1973) 1.21
Prospective assessment of menstrually related mood disorders. Am J Psychiatry (1984) 1.21
Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance. Life Sci (1980) 1.20
Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disord (1986) 1.20
Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci (1997) 1.20
Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol (1992) 1.19
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry (1982) 1.19
Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun (2012) 1.18
Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry (1986) 1.18
Brain regions involved in recognizing facial emotion or identity: an oxygen-15 PET study. J Neuropsychiatry Clin Neurosci (1993) 1.16
Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology (1999) 1.16
Treatment of depression with antiglucocorticoid drugs. Psychosom Med (1999) 1.15
Understanding emotional prosody activates right hemisphere regions. Arch Neurol (1996) 1.11
Cerebral ventricular size in major depressive disorder: association with delusional symptoms. Biol Psychiatry (1983) 1.11
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord (2001) 1.11
Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab (1991) 1.11
Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. Am J Psychiatry (1997) 1.11
Regional cerebral blood flow correlated with flashback intensity in patients with posttraumatic stress disorder. Biol Psychiatry (2001) 1.11
The clinical phenomenology of multiple personality disorder: review of 100 recent cases. J Clin Psychiatry (1986) 1.10
Assortative mating in the affective disorders: a systematic review and meta-analysis. Compr Psychiatry (2001) 1.10
The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry (2000) 1.09
Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry (1999) 1.08
Effects of vasopressin on human memory functions. Science (1981) 1.07
Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry (1980) 1.07
Abnormal facial emotion recognition in depression: serial testing in an ultra-rapid-cycling patient. Behav Modif (1998) 1.07
Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. Neuroreport (1995) 1.06
Lithium-induced thyrotoxicosis. Am J Psychiatry (1979) 1.06
An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am J Med Genet (1996) 1.05
Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). J Psychiatr Res (1998) 1.03
Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci (1981) 1.03
Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry (1984) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol (1990) 1.02
Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci (1983) 1.02
Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry (1988) 1.02
Behavioral disturbances associated with endocrine disorders. Annu Rev Med (1986) 1.02
Transient sensory, cognitive and affective phenomena in affective illness. A comparison with complex partial epilepsy. Br J Psychiatry (1985) 1.01
Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry (2001) 1.01
Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia. Biol Psychiatry (1989) 1.01
CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res (1986) 1.00
Thrombocytopenia and alcoholism. Ann Intern Med (1968) 1.00
Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry (1997) 1.00
Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand (2014) 0.99
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Thinking disorder in depression. Arch Gen Psychiatry (1983) 0.99
Cocaine, kindling, and psychosis. Am J Psychiatry (1976) 0.99